Shanqiang Qu

机构：Nanfang Hospital, Southern Medical University · ORCID：0000-0002-2709-0101

发表论文 70 篇 · 总被引 816 次 · h-index 18

代表论文

• The HBP Pathway Inhibitor FR054 Enhances Temozolomide Sensitivity in Glioblastoma Cells by Promoting Ferroptosis and Inhibiting O‐ GlcNAcylation (2025 · CNS Neuroscience & Therapeutics · 被引 7)
• Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classification (2026 · Clinical Cancer Research · 被引 3)
• Integrating Single‐Cell and Spatial Transcriptomics Reveals NK Cell Subpopulations Associated With Immunotherapy for Melanoma (2025 · Smart Medicine · 被引 2)
• Short-course high-dose methylprednisolone reduces complications and shortens hospital stay after glioblastoma resection: a propensity score-matched cohort study (2026 · Journal of Clinical Neuroscience)
• Clinical, surgical, and molecular characteristics and outcomes of adult patients with diffuse midline glioma, H3 K27-altered, treated with surgical resection (2026 · Journal of Neuro-Oncology)
• Supplementary Figure S4 from Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classification (2026)